{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:10:04Z","timestamp":1790244604892,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"DOI":"10.1186\/s12941-026-00876-1","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:44:35Z","timestamp":1784213075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features of nontuberculous mycobacteria and diagnosis with nanopore targeted sequencing: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Xingyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"876_CR1","unstructured":"World Health Organization. Global tuberculosis report 2024[EB\/OL]. https:\/\/iris.who.int\/handle\/10665\/379339"},{"issue":"10181","key":"876_CR2","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/s0140-6736(19)30308-3","volume":"393","author":"J Furin","year":"2019","unstructured":"Furin J, Cox H, Pai M, Tuberculosis. Lancet. 2019;393(10181):1642\u201356. https:\/\/doi.org\/10.1016\/s0140-6736(19)30308-3.","journal-title":"Lancet"},{"issue":"1","key":"876_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40249-021-00844-1","volume":"10","author":"CF Liu","year":"2021","unstructured":"Liu CF, Song YM, He WC, et al. Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey. Infect Dis Poverty. 2021;10(1):59. https:\/\/doi.org\/10.1186\/s40249-021-00844-1.","journal-title":"Infect Dis Poverty"},{"issue":"10","key":"876_CR4","doi-asserted-by":"publisher","first-page":"e109736","DOI":"10.1371\/journal.pone.0109736","volume":"9","author":"J Wu","year":"2014","unstructured":"Wu J, Zhang Y, Li J, et al. Increase in nontuberculous mycobacteria isolated in Shanghai, China: results from a population-based study. PLoS ONE. 2014;9(10):e109736. https:\/\/doi.org\/10.1371\/journal.pone.0109736.","journal-title":"PLoS ONE"},{"issue":"1","key":"876_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12866-020-01840-5","volume":"20","author":"JJ Huang","year":"2020","unstructured":"Huang JJ, Li YX, Zhao Y, et al. Prevalence of nontuberculous mycobacteria in a tertiary hospital in Beijing, China, January 2013 to December 2018. BMC Microbiol. 2020;20(1):158. https:\/\/doi.org\/10.1186\/s12866-020-01840-5.","journal-title":"BMC Microbiol"},{"key":"876_CR6","doi-asserted-by":"publisher","first-page":"107398","DOI":"10.1016\/j.actatropica.2024.107398","volume":"260","author":"L Deqing","year":"2024","unstructured":"Deqing L, Khan MT, Yaoju T, et al. Increasing trends of non-tuberculous mycobacteria clinical isolates in Guangzhou, China. Acta Trop. 2024;260:107398. https:\/\/doi.org\/10.1016\/j.actatropica.2024.107398.","journal-title":"Acta Trop"},{"issue":"1","key":"876_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s12879-023-08468-6","volume":"23","author":"JE Marshall","year":"2023","unstructured":"Marshall JE, Mercaldo RA, Lipner EM, et al. Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010\u20132019). BMC Infect Dis. 2023;23(1):489. https:\/\/doi.org\/10.1186\/s12879-023-08468-6.","journal-title":"BMC Infect Dis"},{"key":"876_CR8","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1017\/s0950268819001626","volume":"147","author":"J Xu","year":"2019","unstructured":"Xu J, Li P, Zheng S, et al. Prevalence and risk factors of pulmonary nontuberculous mycobacterial infections in the Zhejiang Province of China. Epidemiol Infect. 2019;147:e269. https:\/\/doi.org\/10.1017\/s0950268819001626.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"876_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jinf.2021.05.019","volume":"83","author":"Y Tan","year":"2021","unstructured":"Tan Y, Deng Y, Yan X, et al. Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance study. J Infect. 2021;83(1):46\u201353. https:\/\/doi.org\/10.1016\/j.jinf.2021.05.019.","journal-title":"J Infect"},{"issue":"8","key":"876_CR10","doi-asserted-by":"publisher","first-page":"e055672","DOI":"10.1136\/bmjopen-2021-055672","volume":"12","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Mu W, Zhang J, et al. Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006\u20132021: a systematic review and meta-analysis. BMJ Open. 2022;12(8):e055672. https:\/\/doi.org\/10.1136\/bmjopen-2021-055672.","journal-title":"BMJ Open"},{"issue":"5","key":"876_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jcf.2020.06.016","volume":"19","author":"P De","year":"2020","unstructured":"De P, Amin AG, Graham B, et al. Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway. J Cyst Fibros. 2020;19(5):801\u20137. https:\/\/doi.org\/10.1016\/j.jcf.2020.06.016.","journal-title":"J Cyst Fibros"},{"issue":"8","key":"876_CR12","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s10096-025-05151-3","volume":"44","author":"ZT Fei","year":"2025","unstructured":"Fei ZT, Zhou DP, Huang W, et al. Clinical characteristics and outcomes of tuberculosis and non-tuberculous mycobacteria infections: a population-based study of concurrent and sequential infections. Eur J Clin Microbiol Infect Dis. 2025;44(8):1879\u201387. https:\/\/doi.org\/10.1007\/s10096-025-05151-3.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"876_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367\u2013416. https:\/\/doi.org\/10.1164\/rccm.200604-571ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"876_CR14","doi-asserted-by":"publisher","unstructured":"Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Eur Respir J. 2020. https:\/\/doi.org\/10.1183\/13993003.00535-2020.","DOI":"10.1183\/13993003.00535-2020"},{"issue":"7","key":"876_CR15","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1016\/s1473-3099(21)00586-7","volume":"22","author":"C Lange","year":"2022","unstructured":"Lange C, B\u00f6ttger EC, Cambau E, et al. Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. Lancet Infect Dis. 2022;22(7):e178\u201390. https:\/\/doi.org\/10.1016\/s1473-3099(21)00586-7.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"876_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12890-024-03207-2","volume":"24","author":"J Koh","year":"2024","unstructured":"Koh J, Kim S, Kim JY, et al. Immunologic features of nontuberculous mycobacterial pulmonary disease based on spatially resolved whole transcriptomics. BMC Pulm Med. 2024;24(1):392. https:\/\/doi.org\/10.1186\/s12890-024-03207-2.","journal-title":"BMC Pulm Med"},{"key":"876_CR17","doi-asserted-by":"publisher","first-page":"1205225","DOI":"10.3389\/fcimb.2023.1205225","volume":"13","author":"Q Liu","year":"2023","unstructured":"Liu Q, Du J, An H, et al. Clinical characteristics of patients with non-tuberculous mycobacterial pulmonary disease: a seven-year follow-up study conducted in a certain tertiary hospital in Beijing. Front Cell Infect Microbiol. 2023;13:1205225. https:\/\/doi.org\/10.3389\/fcimb.2023.1205225.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"876_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3760\/cma.j.cn112147-20240808-00471","volume":"48","author":"[Chinese expert consensus on diagnosis","year":"2025","unstructured":"[Chinese expert consensus on diagnosis. and treatment of non-tuberculous mycobacterial pulmonary disease complicated with bronchiectasis]. Zhonghua Jie He He Hu Xi Za Zhi. 2025;48(2):101\u201315. https:\/\/doi.org\/10.3760\/cma.j.cn112147-20240808-00471.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"5","key":"876_CR19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jcf.2019.05.013","volume":"18","author":"B Banaschewski","year":"2019","unstructured":"Banaschewski B, Verma D, Pennings LJ, et al. Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections. J Cyst Fibros. 2019;18(5):714\u201320. https:\/\/doi.org\/10.1016\/j.jcf.2019.05.013.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"876_CR20","doi-asserted-by":"publisher","first-page":"40730","DOI":"10.1038\/s41598-025-24583-7","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, Chen H, Liu J, et al. Distribution and epidemiological characteristics of nontuberculous mycobacterium species in jianghan plain. Sci Rep. 2025;15(1):40730. https:\/\/doi.org\/10.1038\/s41598-025-24583-7.","journal-title":"Sci Rep"},{"issue":"10","key":"876_CR21","doi-asserted-by":"publisher","first-page":"e0055425","DOI":"10.1128\/spectrum.00554-25","volume":"13","author":"TY Kim","year":"2025","unstructured":"Kim TY, Park JS, Kang M, et al. Species distribution of nontuberculous mycobacteria isolated from respiratory specimens at a tertiary care hospital in South Korea, 2017\u20132022. Microbiol Spectr. 2025;13(10):e0055425. https:\/\/doi.org\/10.1128\/spectrum.00554-25.","journal-title":"Microbiol Spectr"},{"key":"876_CR22","doi-asserted-by":"publisher","unstructured":"Kunkel M, Doyle-Eisele M, Kuehl P, et al. Clofazimine inhalation suspension demonstrates promising toxicokinetics in canines for treating pulmonary nontuberculous mycobacteria infection. Antimicrob Agents Chemother. 2023. https:\/\/doi.org\/10.1128\/aac.01144-22.","DOI":"10.1128\/aac.01144-22"},{"issue":"6","key":"876_CR23","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cmi.2024.03.019","volume":"30","author":"M Pozuelo Torres","year":"2024","unstructured":"Pozuelo Torres M, Van Ingen J. Dual \u03b2-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease. Clin Microbiol Infect. 2024;30(6):738\u201342. https:\/\/doi.org\/10.1016\/j.cmi.2024.03.019.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"876_CR24","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/cid\/ciab535","volume":"73","author":"DC Nguyen","year":"2021","unstructured":"Nguyen DC, Dousa KM, Kurz SG, et al. One-Two Punch: Synergistic \u00df-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis Enzymes. Clin Infect Dis. 2021;73(8):1532\u20136. https:\/\/doi.org\/10.1093\/cid\/ciab535.","journal-title":"Clin Infect Dis"},{"key":"876_CR25","doi-asserted-by":"publisher","unstructured":"Dousa KM, Kurz SG, Taracila MA, et al. Insights into the l,d-Transpeptidases and d,d-Carboxypeptidase of Mycobacterium abscessus: Ceftaroline, Imipenem, and Novel Diazabicyclooctane Inhibitors. Antimicrob Agents Chemother. 2020. https:\/\/doi.org\/10.1128\/aac.00098-20.","DOI":"10.1128\/aac.00098-20"},{"issue":"4","key":"876_CR26","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1183\/09031936.00169114","volume":"45","author":"KL Winthrop","year":"2015","unstructured":"Winthrop KL, Ku JH, Marras TK, et al. The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease. Eur Respir J. 2015;45(4):1177\u20139. https:\/\/doi.org\/10.1183\/09031936.00169114.","journal-title":"Eur Respir J"},{"issue":"4","key":"876_CR27","doi-asserted-by":"publisher","first-page":"e0165522","DOI":"10.1128\/aac.01655-22","volume":"67","author":"DA Negatu","year":"2023","unstructured":"Negatu DA, Aragaw WW, Cangialosi J, et al. Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections. Antimicrob Agents Chemother. 2023;67(4):e0165522. https:\/\/doi.org\/10.1128\/aac.01655-22.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"876_CR28","doi-asserted-by":"publisher","first-page":"e0182824","DOI":"10.1128\/aac.01828-24","volume":"69","author":"Y Huang","year":"2025","unstructured":"Huang Y, Chiaraviglio L, Bode-Sojobi I, et al. Triple antimicrobial combinations with potent synergistic activity against M. abscessus. Antimicrob Agents Chemother. 2025;69(4):e0182824. https:\/\/doi.org\/10.1128\/aac.01828-24.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"876_CR29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/jac\/dkae461","volume":"80","author":"MH Nguyen","year":"2025","unstructured":"Nguyen MH, Calado Nogueira De Moura V, Keepers TR, et al. In vitro susceptibility of 147 international clinical Mycobacterium abscessus isolates to epetraborole and comparators by broth microdilution. J Antimicrob Chemother. 2025;80(3):713\u20136. https:\/\/doi.org\/10.1093\/jac\/dkae461.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"876_CR30","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.cell.2022.04.024","volume":"185","author":"JA Nick","year":"2022","unstructured":"Nick JA, Dedrick RM, Gray AL, et al. Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection. Cell. 2022;185(11):1860\u2013e18741812. https:\/\/doi.org\/10.1016\/j.cell.2022.04.024.","journal-title":"Cell"},{"key":"876_CR31","doi-asserted-by":"publisher","unstructured":"Licata MA, Mencarini P, Mastrobattista A, et al. Clinical utility of induced sputum and bronchoalveolar lavage cultures in diagnosing nontuberculous mycobacterial pulmonary disease. Pathogens. 2024. https:\/\/doi.org\/10.3390\/pathogens13121064.","DOI":"10.3390\/pathogens13121064"},{"key":"876_CR32","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.2147\/idr.S417088","volume":"16","author":"X Zhang","year":"2023","unstructured":"Zhang X, Chen H, Lin Y, et al. Diagnosis of Non-Tuberculous Mycobacterial Pulmonary Disease by Metagenomic Next-Generation Sequencing on Bronchoalveolar Lavage Fluid. Infect Drug Resist. 2023;16:4137\u201345. https:\/\/doi.org\/10.2147\/idr.S417088.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"876_CR33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ccm.2023.06.001","volume":"44","author":"R Khare","year":"2023","unstructured":"Khare R, Brown-Elliott BA, Culture. Identification, and Antimicrobial Susceptibility Testing of Pulmonary Nontuberculous Mycobacteria. Clin Chest Med. 2023;44(4):743\u201355. https:\/\/doi.org\/10.1016\/j.ccm.2023.06.001.","journal-title":"Clin Chest Med"},{"issue":"8","key":"876_CR34","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.62347\/hhrh8076","volume":"16","author":"WH Lin","year":"2024","unstructured":"Lin WH, Tang F, Liu SS. Diagnostic value of nanopore sequencing technology in nontuberculous mycobacterial pulmonary disease. Am J Transl Res. 2024;16(8):4208\u201315. https:\/\/doi.org\/10.62347\/hhrh8076.","journal-title":"Am J Transl Res"},{"issue":"9","key":"876_CR35","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/ceo.13992","volume":"49","author":"Q Huang","year":"2021","unstructured":"Huang Q, Fu A, Wang Y, et al. Microbiological diagnosis of endophthalmitis using nanopore targeted sequencing. Clin Exp Ophthalmol. 2021;49(9):1060\u20138. https:\/\/doi.org\/10.1111\/ceo.13992.","journal-title":"Clin Exp Ophthalmol"},{"key":"876_CR36","doi-asserted-by":"publisher","first-page":"943441","DOI":"10.3389\/fmicb.2022.943441","volume":"13","author":"C Bouchiat","year":"2022","unstructured":"Bouchiat C, Ginevra C, Benito Y, et al. Improving the Diagnosis of Bacterial Infections: Evaluation of 16S rRNA Nanopore Metagenomics in Culture-Negative Samples. Front Microbiol. 2022;13:943441. https:\/\/doi.org\/10.3389\/fmicb.2022.943441.","journal-title":"Front Microbiol"},{"key":"876_CR37","doi-asserted-by":"publisher","first-page":"151663","DOI":"10.1016\/j.ijmm.2025.151663","volume":"320","author":"LP Cheng","year":"2025","unstructured":"Cheng LP, Wang L, Wang YF, et al. Nanopore-targeted sequencing: A new and effective technique for the diagnosis of non-tuberculous mycobacteria pulmonary disease. Int J Med Microbiol. 2025;320:151663. https:\/\/doi.org\/10.1016\/j.ijmm.2025.151663.","journal-title":"Int J Med Microbiol"},{"issue":"8","key":"876_CR38","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1513\/pats.200602-015MS","volume":"3","author":"L Huang","year":"2006","unstructured":"Huang L, Morris A, Limper AH, et al. An Official ATS Workshop Summary: Recent advances and future directions in pneumocystis pneumonia (PCP). Proc Am Thorac Soc. 2006;3(8):655\u201364. https:\/\/doi.org\/10.1513\/pats.200602-015MS.","journal-title":"Proc Am Thorac Soc"},{"issue":"4","key":"876_CR39","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/jim-2016-000381","volume":"65","author":"EL Davey","year":"2017","unstructured":"Davey EL, Colombo RE, Fiorentino C, et al. Pneumocystis colonization in asthmatic patients not receiving oral corticosteroid therapy. J Investig Med. 2017;65(4):800\u20132. https:\/\/doi.org\/10.1136\/jim-2016-000381.","journal-title":"J Investig Med"},{"issue":"5","key":"876_CR40","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.bjid.2019.08.008","volume":"23","author":"A Ca\u00f1as-Arboleda","year":"2019","unstructured":"Ca\u00f1as-Arboleda A, Hern\u00e1ndez-Fl\u00f3rez C, Garz\u00f3n J, et al. Colonization by Pneumocystis jirovecii in patients with chronic obstructive pulmonary disease: association with exacerbations and lung function status. Braz J Infect Dis. 2019;23(5):352\u20137. https:\/\/doi.org\/10.1016\/j.bjid.2019.08.008.","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"876_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12890-020-1111-4","volume":"20","author":"T Xue","year":"2020","unstructured":"Xue T, Ma Z, Liu F, et al. Pneumocystis jirovecii colonization and its association with pulmonary diseases: a multicenter study based on a modified loop-mediated isothermal amplification assay. BMC Pulm Med. 2020;20(1):70. https:\/\/doi.org\/10.1186\/s12890-020-1111-4.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"876_CR42","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s13054-023-04608-1","volume":"27","author":"DR Giacobbe","year":"2023","unstructured":"Giacobbe DR, Dettori S, Di Pilato V, et al. Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG. Crit Care. 2023;27(1):323. https:\/\/doi.org\/10.1186\/s13054-023-04608-1.","journal-title":"Crit Care"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-026-00876-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-026-00876-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-026-00876-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:39:04Z","timestamp":1790242744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12941-026-00876-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["876"],"URL":"https:\/\/doi.org\/10.1186\/s12941-026-00876-1","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received approval from the Human Research Ethics and System Review Committee of the Second Hospital of Nanjing (ID: 2025-LS-ky112). Informed consent was obtained from all the participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all the participants in this study as well as the co-authors.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"37"}}